Phychem Technologies IPO Financials, Risk Factors, Peers & Objects of Issue
An investor-focused breakdown of the Phychem Technologies IPO offer document: restated financial performance, key ratios, valuation across the price band, competitive strengths, risk factors, listed peers, objects of the issue and the business model, all drawn from the company's RHP disclosures.
Back to the Phychem Technologies IPO report → (allotment, subscription, GMP)
Phychem Technologies IPO Financial Performance (Restated)
On a restated consolidated basis, the company revenue increased by 12% and profit after tax (PAT) rose by 44% between the financial year ending with March 31, 2026, a useful one-line read on operating momentum heading into the listing.
Here is how the books have moved over the last three financial years:
31 Mar 2026 to 31 Mar 2024₹ Crore
All figures in ₹ Crore unless stated otherwise. Source: restated financials disclosed in the offer documents.
Profits have scaled from ₹1.69 Cr to ₹4.09 Cr over two years; the borrowings-to-net-worth ratio has eased to about 0.43. For investors, the trend matters more than any single year, steady compounding with contained leverage is what institutional bidders typically reward, while a late spike in borrowings deserves scrutiny against the stated objects of the issue.
Phychem Technologies IPO Key Performance Indicators (KPI)
ROE34.82%
RoCE32.73%
Return on Net Worth29.66%
Debt / Equity0.43
NAV per share18.29
Price to Book4.20
Reading these numbers. RoE and RoCE measure how efficiently the business turns shareholder capital into profit; anything in double digits is respectable, mid-twenties plus is strong. A debt-to-equity ratio well below 1 signals a balance sheet that does not depend on lenders. NAV per share anchors the book value of your bid, while price-to-book tells you how many rupees the issue is charging for each rupee of that book, compare it with listed peers in the same sector before deciding whether the premium is justified.
Phychem Technologies IPO Valuation, Pre IPO vs Post IPO
The issue price converts into a different earnings multiple once the fresh shares hit the books. Here is the dilution-adjusted picture:
EPS (₹)5.42→ 3.99 post-IPO
P/E (x)9.96→ 13.53 post-IPO
Market Cap at offer₹41Cr→ ₹55.30 Cr post-IPO
Pre-IPO figures are computed on the pre-issue share count; post-IPO figures assume full subscription at the upper band.
Phychem Technologies IPO Competitive Strengths (as disclosed in the RHP)
Key strengths
- Manufactures a wide range of roto moulding compounds including Color Powders (Rs. 2,571.99 lakhs, 45.55% of sales in FY25-26), Stone effect compound (Rs. 1,301.44 lakhs, 23.05%), PE Foam compound (Rs. 861.17 lakhs, 15.25%), and other specialized compounds like Flame retardant and Permanent antistatic compounds
- Diversified revenue across 9 industries including Building & Construction, Automobile, Marine, Furniture, Toys, Agriculture, Chemical, Sewage Treatment, and Railway, preventing customer concentration risks
- Maintains long-term relationships with 265 domestic and 24 global customers during FY25-26, with 142 customers placing repeat orders over the last 3 years
- Top 10 customers contributed 52.99% of revenue in FY25-26, with the largest customer accounting for only 15.73%, indicating balanced customer concentration
- Geographically diversified revenue base with 76.68% from domestic markets (led by Maharashtra at 54.60%) and 23.32% from exports across 8+ countries including Guinea (7.98%), Mauritius (4.59%), and Cameroon (3.36%) in FY25-26
- Operates three fully functional rotational moulding machines at Nashik, Maharashtra facility with in-house quality control systems and equipment including Melt Flow Index Tester, Impact tester, and Single Station Pressure Tester
- Wide range of products serving diverse applications in the roto moulding industry.
- In-house manufacturing facility with equipped machinery and processes.
- Long-standing relationships with diversified customers across geographies.
- Strong focus on Quality, Environment, Health and Safety.
Phychem Technologies IPO Business Model
- The provided excerpt does not contain information about the company's main products, services, revenue model, customers, manufacturing capacity, or locations.
- The excerpt only includes standard IPO issue structure, book building procedure, market making arrangements, and regulatory disclosures.
- No details are provided about what the company actually manufactures, sells, or where it operates.
Phychem Technologies IPO Industry Snapshot
- The company operates in the plastics/polymer sector, importing polymers, additives, or equipment, and is regulated by the Plastic Waste Management (PWM) Rules, 2016.
- The PWM Rules, 2016 mandate Extended Producer Responsibility (EPR) for producers, importers, and brand owners to collect and recycle plastic waste, and prohibit the manufacture and use of plastic carry bags and sachets less than 50 microns in thickness.
- The PWM Rules, 2016 promote the use of plastic waste for road construction and energy recovery, encouraging sustainable waste management practices.
- The Government of India brought four labour codes into effect from November 21, 2025, consolidating laws on wages, industrial relations, occupational safety, and social security.
- The Income Tax Act, 2025 replaces the Income Tax Act, 1961 effective from 1 April 2026, introducing a simplified tax structure and a single 'tax year'.
- Imports of polymers, additives, or equipment are subject to customs valuation under the Customs Valuation Rules, 2007, requiring correct transaction value declaration to avoid penalties.
Phychem Technologies IPO Objects of the Issue
Repayment in full or in part, of certain of our outstanding borrowings25.00
Funding the capital expenditure towards procurement of plant and machinery51.49
Funding to meet working capital requirements30.00
General Corporate Purpose[●]
Phychem Technologies IPO Litigation
- Direct Tax (TDS Defaults)
- Direct Tax
Disclaimer: The financial data on this page is auto-extracted from the company's offer document (RHP/DRHP) and is provided for education only. DostIpo is not a SEBI-registered investment adviser; verify all figures against the official prospectus before making any investment decision. Investments in the securities market are subject to market risks.
View the complete Phychem Technologies IPO report: allotment status, subscription, GMP & review →
Last updated: 02 Sep 2026, 22:23 IST